Download PDF

Journal of Crohns & Colitis

Publication date: 2017-01-01
Volume: 11 25
Publisher: Elsevier Science BV

Author:

Gomollon, Fernando
Dignass, Axel ; Annese, Vito ; Tilg, Herbert ; Van Assche, Gert ; Lindsay, James O ; Peyrin-Biroulet, Laurent ; Cullen, Garret J ; Daperno, Marco ; Kucharzik, Torsten ; Rieder, Florian ; Almer, Sven O ; Armuzzi, Alessandro ; Harbord, Marcus ; Langhorst, Jost ; Sans, Miquel ; Chowers, Yehuda ; Fiorino, Gionata ; Juillerat, Pascal ; Mantzaris, Gerassimos J ; Rizzello, Fernando ; Vavricka, Stephan ; Gionchetti, Paolo ; Bossuyt, Peter

Keywords:

Crohn's disease, biologics, fistulizing disease, Immunosuppressant, perianal disease, steroids, strictureplasty, thiopurine, treatment, vedolizumab, Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, Crohn’s disease, Crohn Disease, Endoscopy, Gastrointestinal, Evidence-Based Medicine, Humans, Intestines, Magnetic Resonance Imaging, Recurrence, Remission Induction, Tomography, X-Ray Computed, ECCO, 1103 Clinical Sciences, 3202 Clinical sciences

Abstract:

This paper is the first in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn's disease. Surgical management as well as special situations including management of perianal Crohn's disease of this ECCO Consensus are covered in a subsequent second paper [Gionchetti et al JCC 2016].